An Act relative to pharmaceutical access, costs and transparency

Reported by Joint Committee on Health Care Financing · 38 cosponsors · 193rd General Court · the legislature's own page

S2492 · Bill

7 actions

In the order the legislature recorded them.

Date	Branch	Action
2023-10-30	Senate	Reported from the committee on Health Care Financing
2023-10-30	Senate	New draft of S732, S749, S767, S778, S783, S784, S797, H619, H1176, H1201, H1205, H1206, H1215, H1246 and H1247
2023-10-30	Senate	Bill reported favorably by committee and referred to the committee on Senate Ways and Means
2023-11-09	Senate	Committee recommended ought to pass with an amendment, substituting a new draft, see S2499
2023-11-09	Senate	Order relative to subject matter adopted
2023-11-09	Senate	Placed in the Orders of the Day for Wednesday, November 15, 2023
2023-11-15	Senate	Read second

1 adopted, as amended

No.	Title	Moved by	Outcome
Senate 1	An Act relative to pharmaceutical access, costs and transparency	Senate Committee on Ways and Means	Adopted, as Amended

Ways and Means (S) · 2023-11-09 13:30 · Ought to pass – by substitution of a New Draft

Positions are the four the committee itself records. Reserving a right is not an abstention and no action is not an absence.

Action	Committee
Redraft	Health Care Financing (J)
Favorable with Amendment	Ways and Means (S)

In the order filed.

Every action here is as the legislature published it. A bill that drew no recorded vote is the ordinary case: the House records roughly 150 a year.